Physician profile
Mark Steven Stern
NPI 1649282765
$87,375.02
in general payments reported to CMS, 2019-2025
43 companies · $344 in 2025
The $344 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,891 · 2020: $26K · 2021: $43K · 2022: $2,536 · 2023: $10K · 2024: $3,461 · 2025: $344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $10K · Food and Beverage: $3,420 · Entertainment: $18.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,400.00 |
| Food and Beverage | $3,420.09 |
| Entertainment | $18.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aurora Spine, INC. | $60,000.00 | 2020-2021 | |
| Kyocera Medical Technologies, INC. | $10,400.00 | 2023-2024 | |
| Medtronic, INC. | $5,282.44 | 2021-2025 | Intellis Adaptivestim, Synchromedii, Prestige LP Cervical Disc System |
| Davol INC. | $3,035.05 | 2021 | |
| Si-Bone, INC. | $2,008.48 | 2019-2024 | |
| Nevro Corp. | $1,923.81 | 2019-2024 | Senza |
| Medtronic USA, INC. | $988.02 | 2019-2020 | |
| Globus Medical, INC. | $686.33 | 2020-2023 | Independence Mis |
| Centinel Spine, LLC | $597.98 | 2019-2023 | Prodisc L, Prodisc C Vivo |
| Zimmer Biomet Holdings, INC. | $463.74 | 2019-2021 | |
| Depuy Synthes Sales INC. | $268.18 | 2019-2024 | Vivigen Mis Delivery System, Fibergraft Bg Morsels |
| Stimwave Technologies Incorporated | $205.49 | 2019 | |
| Tersera Therapeutics LLC | $164.04 | 2019-2024 | Prialt |
| Neuronetics, INC. | $140.11 | 2020-2021 | |
| Integra Lifesciences Corporation | $131.84 | 2025 | Codman Hakim, Cusa Clarity, Codman Certas |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Stern listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.